NCT02503332[Secondary Source ID] - Search Results

Year	Number of Results
2022	4
2023	3
2024	1
2025	1
2026	0

1

A Novel Management Challenge in Age-Related Macular Degeneration: Artificial Intelligence and Expert Prediction of Geographic Atrophy.

Reiter GS, Lachinov D, Bühl W, Weigert G, Grechenig C, Mai J, Bogunović H, Schmidt-Erfurth U. Reiter GS, et al. Ophthalmol Retina. 2025 May;9(5):421-430. doi: 10.1016/j.oret.2024.10.029. Epub 2024 Nov 9. Ophthalmol Retina. 2025. PMID: 39522752 Free article.

2

Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy.

Pfau M, Schmitz-Valckenberg S, Ribeiro R, Safaei R, McKeown A, Fleckenstein M, Holz FG. Pfau M, et al. Sci Rep. 2022 Oct 25;12(1):17870. doi: 10.1038/s41598-022-22404-9. Sci Rep. 2022. PMID: 36284220 Free PMC article. Clinical Trial.

3

Complement inhibitors for age-related macular degeneration.

Tzoumas N, Riding G, Williams MA, Steel DH. Tzoumas N, et al. Cochrane Database Syst Rev. 2023 Jun 14;6(6):CD009300. doi: 10.1002/14651858.CD009300.pub3. Cochrane Database Syst Rev. 2023. PMID: 37314061 Free PMC article. Review.

4

Predicting Topographic Disease Progression and Treatment Response of Pegcetacoplan in Geographic Atrophy Quantified by Deep Learning.

Vogl WD, Riedl S, Mai J, Reiter GS, Lachinov D, Bogunović H, Schmidt-Erfurth U. Vogl WD, et al. Ophthalmol Retina. 2023 Jan;7(1):4-13. doi: 10.1016/j.oret.2022.08.003. Epub 2022 Aug 7. Ophthalmol Retina. 2023. PMID: 35948209 Free article. Clinical Trial.

5

Evaluating the Effects of C3 Inhibition on Geographic Atrophy Progression from Deep-Learning OCT Quantification: A Split-Person Study.

Fu DJ, Lipkova V, Liefers B, Glinton S, Faes L, McKeown A, Scheibler L, Pontikos N, Patel PJ, Zhang G, Keane PA, Balaskas K. Fu DJ, et al. Ophthalmol Ther. 2023 Dec;12(6):3143-3158. doi: 10.1007/s40123-023-00798-7. Epub 2023 Sep 16. Ophthalmol Ther. 2023. PMID: 37715860 Free PMC article.

6

Pegcetacoplan treatment for geographic atrophy due to age-related macular degeneration: a plain language summary of the FILLY study.

Liao DS, Metlapally R, Joshi P. Liao DS, et al. Immunotherapy. 2022 Sep;14(13):995-1006. doi: 10.2217/imt-2022-0078. Epub 2022 Jul 21. Immunotherapy. 2022. PMID: 35860926 Free article.

7

Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration: A Post Hoc Analysis of the FILLY Randomized Clinical Trial.

Nittala MG, Metlapally R, Ip M, Chakravarthy U, Holz FG, Staurenghi G, Waheed N, Velaga SB, Lindenberg S, Karamat A, Koester J, Ribeiro R, Sadda S. Nittala MG, et al. JAMA Ophthalmol. 2022 Mar 1;140(3):243-249. doi: 10.1001/jamaophthalmol.2021.6067. JAMA Ophthalmol. 2022. PMID: 35113137 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year